MT-MMPS as regulators of vessel stability associated with angiogenesis

Frontiers in Pharmacology

Volumn MAY, Issue , 2011, Pages

  Sounni, Nor Eddine ^a   Paye, Alexandra ^a   Host, Lorin ^a   Noël, Agnès ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Collagen; Interstitial fluid pressure; Mmps; Mt mmps; Vessel permeability

Indexed keywords

COLLAGEN; COLLAGEN TYPE 1; ENDOGLIN; LAMININ; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 17; MEMBRANE TYPE MATRIX METALLOPROTEINASE; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; BASEMENT MEMBRANE; BLOOD VESSEL PERMEABILITY; CANCER GROWTH; CELL FATE; COLLAGEN DEGRADATION; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; MATURATION; METASTASIS; NONHUMAN; PERICYTE; PROTEIN DEGRADATION; STROMA; SUBRETINAL NEOVASCULARIZATION; TISSUE PRESSURE; TUMOR GROWTH; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION;

EID: 81255196235     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2011.00111     Document Type: Article

References (125)

1. Ahn, G. O., and Brown, J. M. (2008). Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: role of bone marrow- derived myelomonocytic cells. Cancer Cell 13, 193-205.
2. Akalu, A., Roth, J. M., Caunt, M., Policarpio, D., Liebes, L., and Brooks, P. C. (2007). Inhibition of angiogenesis and tumor metastasis by targeting a matrix immobilized cryptic extracel- lular matrix epitope in laminin. Cancer Res. 67, 4353-4363.
3. Aviezer, D., Hecht, D., Safran, M., Eisinger, M., David, G., and Yayon, A. (1994). Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis. Cell 79, 1005-1013.
4. Baluk, P., Hashizume, H., and McDonald, D. M. (2005). Cellular abnormalities of blood vessels as targets in cancer. Curr. Opin. Genet. Dev. 15, 102-111.
5. Baluk, P., Morikawa, S., Haskell, A., Mancuso, M., and McDonald, D. M. (2003). Abnormalities of basement membrane on blood vessels and endothelial sprouts in tumors. Am. J. Pathol. 163, 1801-1815.
6. Basson, C. T., Knowles, W. J., Bell, L., Albelda, S. M., Castronovo, V., Liotta, L. A., and Madri, J. A. (1990). Spatiotemporal segregation of endothelial cell integrin and nonin- tegrin extracellular matrix-binding proteins during adhesion events. J. Cell Biol. 110, 789-801.
7. Benjamin, L. E., Golijanin, D., Itin, A., Pode, D., and Keshet, E. (1999). Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. J. Clin. Invest. 103, 159-165.
8. Bergers, G., Brekken, R., McMahon, G., Vu, T. H., Itoh, T., Tamaki, K., Tanzawa, K., Thorpe, P., Itohara, S., Werb, Z., and Hanahan, D. (2000). Matrix metallo- proteinase-9 triggers the angiogenic switch during carcinogenesis. Nat. Cell Biol. 2, 737-744.
9. Bix, G., Iozzo, R. A., Woodall, B., Burrows, M., McQuillan, A., Campbell, S., Fields, G. B., and Iozzo, R. V. (2007). Endorepellin, the C-terminal angi- ostatic module of perlecan, enhances collagen-platelet responses via the alpha2beta1-integrin receptor. Blood 109, 3745-3748.
10. Boudreau, N. J., and Jones, P. L. (1999). Extracellular matrix and integrin sig- nalling: the shape of things to come. Biochem. J. 339(Pt 3), 481-488.
11. Brown, E., McKee, T., diTomaso, E., Pluen, A., Seed, B., Boucher, Y., and Jain, R. K. (2003). Dynamic imaging of collagen and its modulation in tumors in vivo using second-harmonic generation. Nat. Med. 9, 796-800.
12. Chabottaux, V., Ricaud, S., Host, L., Blacher, S., Paye, A., Thiry, M., Garofalakis, A., Pestourie, C., Gombert, K., Bruyere, F., Lewandowsky, D., Tavitian, B., Foidart, J. M., Duconge, F., and Noel, A. (2009). Membrane-type 4 matrix metallopro- teinase (MT4-MMP) induces lung metastasis by alteration of primary breast tumour vascular architecture. J. Cell. Mol. Med. 13, 4002-4013.
13. Chabottaux, V., Sounni, N. E., Pennington, C. J., English, W. R., van den Brule, F., Blacher, S., Gilles, C., Munaut, C., Maquoi, E., Lopez-Otin, C., Murphy, G., Edwards, D. R., Foidart, J. M., and Noël, A. (2006). Membrane-type 4 matrix metalloproteinase promotes breast cancer growth and metastases. Cancer Res. 66, 5165-5172.
14. Chantrain, C., Shimada, H., Jodele, S., Groshen, S., Ye, W., Shalinsky, D., Werb, Z., Coussens, L. M., and DeClerck, Y. A. (2004). Stromal matrix metalloproteinase-9 regulates the vas- cular architecture in neuroblastoma by promoting pericyte recruitment. Cancer Res. 64, 1675-1686.
15. Chantrain, C. F., Henriet, P., Jodele, S., Emonard, H., Feron, O., Courtoy, P. J., DeClerck, Y. A., and Marbaix, E. (2006). Mechanisms of pericyte recruitment in tumour angiogenesis: a new role for metalloproteinases. Eur. J. Cancer 42, 310-318.
16. Chun, T. H., Sabeh, F., Ota, I., Murphy, H., McDonagh, K. T., Holmbeck, K., Birkedal-Hansen, H., Allen, E. D., and Weiss, S. J. (2004). MT1-MMP- dependent neovessel formation within the confines of the three-dimensional extracellular matrix. J. Cell Biol. 167, 757-767.
17. Collen, A., Hanemaaijer, R., Lupu, F., Quax, P. H., Van Lent, N., Grimbergen, J., Peters, E., Koolwijk, P., and Van Hinsbergh, V. W. (2003). Membrane- type matrix metalloproteinase-medi- ated angiogenesis in a fibrin-collagen matrix. Blood 101, 1810-1817.
18. Coussens, L. M., Tinkle, C. L., Hanahan, D., and Werb, Z. (2000). MMP-9 sup- plied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 103, 481-490.
19. Cretu, A., Roth, J. M., Caunt, M., Akalu, A., Policarpio, D., Formenti, S., Gagne, P., Liebes, L., and Brooks, P. C. (2007). Disruption of endothelial cell interac- tions with the novel HU177 cryptic collagen epitope inhibits angiogenesis. Clin. Cancer Res. 13, 3068-3078.
20. Dallas, S. L., Rosser, J. L., Mundy, G. R., and Bonewald, L. F. (2002). Proteolysis of latent transforming growth factor- beta (TGF-beta)- binding protein-1 by osteoclasts. A cellular mechanism for release of TGF-beta from bone matrix. J. Biol. Chem. 277, 21352-21360.
21. Dangi-Garimella, S., Redig, A. J., Shields, M. A., Siddiqui, M. A., and Munshi, H. G. (2010). Rho-rock-myosin signal- ing mediates membrane type 1 matrix metalloproteinase-induced cellular aggregation of keratinocytes. J. Biol. Chem. 285, 28363-28372.
22. Dangi-Garimella, S., Strouch, M. J., Grippo, P. J., Bentrem, D. J., and Munshi, H. G. (2011). Collagen regulation of let-7 in pancreatic can- cer involves TGF-beta1-mediated membrane type 1-matrix metallo- proteinase expression. Oncogene 30, 1002-1008.
23. Davis, G. E., and Senger, D. R. (2008). Extracellular matrix mediates a molecular balance between vascular morphogenesis and regression. Curr. Opin. Hematol. 15, 197-203.
24. DeClerck, Y. A., Mercurio, A. M., Stack, M. S., Chapman, H. A., Zutter, M. M., Muschel, R. J., Raz, A., Matrisian, L. M., Sloane, B. F., Noel, A., Hendrix, M. J., Coussens, L., and Padarathsingh, M. (2004). Proteases, extracellular matrix, and cancer: a workshop of the path B study section. Am. J. Pathol. 164, 1131-1139.
25. Deng, Y. P., Li, W., Li, Y. L., Xu, H., Liang, S. S., and Zhang, L. H. (2009). MT1- MMP up-regulates VEGF expression in human breast carcinoma MCF-7 cells and induces tumor angiogenesis. Zhonghua Zhong Liu Za Zhi 31, 727-731.
26. Deryugina, E. I., Soroceanu, L., and Strongin, A. Y. (2002). Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metallo- proteinase stimulates human glioma xenograft growth and angiogenesis. Cancer Res. 62, 580-588.
27. Eberhard, A., Kahlert, S., Goede, V., Hemmerlein, B., Plate, K. H., and Augustin, H. G. (2000). Heterogeneity of angiogenesis and blood vessel maturation in human tumors: impli- cations for antiangiogenic tumor therapies. Cancer Res. 60, 1388-1393.
28. Egeblad, M., Shen, H. C., Behonick, D. J., Wilmes, L., Eichten, A., Korets, L. V., Kheradmand, F., Werb, Z., and Coussens, L. M. (2007). Type I col- lagen is a genetic modifier of matrix metalloproteinase 2 in murine skel- etal development. Dev. Dyn. 236, 1683-1693.
29. Egeblad, M., and Werb, Z. (2002). New functions for the matrix metallopro- teinases in cancer progression. Nat. Rev. Cancer 2, 161-174.
30. Eguchi, S., Dempsey, P. J., Frank, G. D., Motley, E. D., and Inagami, T. (2001). Activation of MAPKs by angiotensin II in vascular smooth muscle cells. Metalloprotease-dependent EGF receptor activation is required for acti- vation of ERK and p38 MAPK but not for JNK. J. Biol. Chem. 276, 7957-7962.
31. Eisenach, P. A., Roghi, C., Fogarasi, M., Murphy, G., and English, W. R. (2010). MT1-MMP regulates VEGF-A expres- sion through a complex with VEGFR-2 and Src. J. Cell Sci. 123, 4182-4193.
32. Favier, J., Germain, S., Emmerich, J., Corvol, P., and Gasc, J. M. (2005). Critical overexpression of throm- bospondin 1 in chronic leg ischaemia. J. Pathol. 207, 358-366.
33. Feron, O. (2004). Targeting the tumor vascular compartment to improve conventional cancer therapy. Trends Pharmacol. Sci. 25, 536-542.
34. Findley, C. M., Cudmore, M. J., Ahmed, A., and Kontos, C. D. (2007). VEGF induces Tie2 shedding via a phosph- oinositide 3-kinase/Akt dependent pathway to modulate Tie2 signaling. Arterioscler. Thromb. Vasc. Biol. 27, 2619-2626.
35. Gee, M. S., Procopio, W. N., Makonnen, S., Feldman, M. D., Yeilding, N. M., and Lee, W. M. (2003). Tumor vessel devel- opment and maturation impose limits on the effectiveness of anti-vascular therapy. Am. J. Pathol. 162, 183-193.
36. Gerhardt, H., and Semb, H. (2008). Pericytes: gatekeepers in tumour cell metastasis? J. Mol. Med. 86, 135-144.
37. Gilles, C., Polette, M., Seiki, M., Birembaut, P., and Thompson, E. W. (1997). Implication of collagen type I-induced membrane-type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma. Lab. Invest. 76, 651-660.
38. Gocheva, V., Zeng, W., Ke, D., Klimstra, D., Reinheckel, T., Peters, C., Hanahan, D., and Joyce, J. A. (2006). Distinct roles for cysteine cathepsin genes in multistage tumorigenesis. Genes Dev. 20, 543-556.
39. Gonzalez, E. M., Reed, C. C., Bix, G., Fu, J., Zhang, Y., Gopalakrishnan, B., Greenspan, D. S., and Iozzo, R. V. (2005). BMP-1/tolloid-like met- alloproteases process endorepellin, the angiostatic C-terminal fragment of perlecan. J. Biol. Chem. 280, 7080-7087.
40. Grant, D. S., Tashiro, K., Segui-Real, B., Yamada, Y., Martin, G. R., and Kleinman, H. K. (1989). Two differ- ent laminin domains mediate the dif- ferentiation of human endothelial cells into capillary-like structures in vitro. Cell 58, 933-943.
41. Hawinkels, L. J., Kuiper, P., Wiercinska, E., Verspaget, H. W., Liu, Z., Pardali, E., Sier, C. F., and ten Dijke, P. (2010). Matrix metalloproteinase-14 (MT1- MMP)-mediated endoglin shedding inhibits tumor angiogenesis. Cancer Res. 70, 4141-4150.
42. Heissig, B., Hattori, K., Dias, S., Friedrich, M., Ferris, B., Hackett, N. R., Crystal, R. G., Besmer, P., Lyden, D., Moore, M. A., Werb, Z., and Rafii, S. (2002). Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 109, 625-637.
43. Heldin, C. H., Rubin, K., Pietras, K., and Ostman, A. (2004). High interstitial fluid pressure - an obstacle in cancer therapy. Nat. Rev. Cancer 4, 806-813.
44. Hendrix, M. J., Seftor, E. A., Hess, A., and Seftor, R. E. (2003). Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma. Nat. Rev. Cancer 3, 411-421.
45. Hibino, S., Shibuya, M., Engbring, J. A., Mochizuki, M., Nomizu, M., and Kleinman, H. K. (2004). Identification of an active site on the laminin alpha5 chain globular domain that binds to CD44 and inhibits malignancy. Cancer Res. 64, 4810-4816.
46. Hiraoka, N., Allen, E., Apel, I. J., Gyetko, M. R., and Weiss, S. J. (1998). Matrix metalloproteinases regulate neovas- cularization by acting as pericellular fibrinolysins. Cell 95, 365-377.
47. Holmbeck, K., Bianco, P., Caterina, J., Yamada, S., Kromer, M., Kuznetsov, S. A., Mankani, M., Robey, P. G., Poole, A. R., Pidoux, I., Ward, J. M., and Birkedal-Hansen, H. (1999). MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inad- equate collagen turnover. Cell 99, 81-92.
48. Hotary, K. B., Allen, E. D., Brooks, P. C., Datta, N. S., Long, M. W., and Weiss, S. J. (2003). Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three- dimensional extracellular matrix. Cell 114, 33-45.
49. Hotary, K. B., Yana, I., Sabeh, F., Li, X. Y., Holmbeck, K., Birkedal-Hansen, H., Allen, E. D., Hiraoka, N., and Weiss, S. J. (2002). Matrix metalloprotein- ases (MMPs) regulate fibrin-invasive activity via MT1-MMP-dependent and -independent processes. J. Exp. Med. 195, 295-308.
50. Huang, S., Van Arsdall, M., Tedjarati, S., McCarty, M., Wu, W., Langley, R., and Fidler, I. J. (2002). Contributions of stromal metalloproteinase-9 to angio- genesis and growth of human ovarian carcinoma in mice. J. Natl. Cancer Inst. 94, 1134-1142.
51. Im, E., and Kazlauskas, A. (2006). New insights regarding vessel regression. Cell Cycle 5, 2057-2059.
52. Im, E., Motiejunaite, R., Aranda, J., Park, E. Y., Federico, L., Kim, T. I., Clair, T., Stracke, M. L., Smyth, S., and Kazlauskas, A. (2010). Phospholipase Cgamma activation drives increased production of autotaxin in endothe- lial cells and lysophosphatidic acid- dependent regression. Mol. Cell. Biol. 30, 2401-2410.
53. Imai, K., Hiramatsu, A., Fukushima, D., Pierschbacher, M. D., and Okada, Y. (1997). Degradation of decorin by matrix metalloproteinases: identifica- tion of the cleavage sites, kinetic analyses and transforming growth factor-beta1 release. Biochem. J. 322, 809-814.
54. Iozzo, R. V. (2005). Basement membrane proteoglycans: from cellar to ceiling. Nat. Rev. Mol. Cell Biol. 6, 646-656.
55. Jain, R. K. (2003). Molecular regulation of vessel maturation. Nat. Med. 9, 685-693.
56. Jain, R. K. (2005). Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 307, 58-62.
57. Kalluri, R. (2003). Basement membranes: structure, assembly and role in tumour angiogenesis. Nat. Rev. Cancer 3, 422-433.
58. Kamioka, M., Ishibashi, T., Ohkawara, H., Eguchi, R., Sugimoto, K., Uekita, H., Matsui, T., Yamagishi, S. I., Ando, K., Sakamoto, T., Sakamoto, N., Takuwa, Y., Wada, I., Shiomi, M., Maruyama, Y., and Takeishi, Y. (2011). Involvement of membrane type 1-matrix metalloproteinase (MT1-MMP) in rage activation signaling pathways. J. Cell. Physiol. 226, 1554-1563.
59. Kessenbrock, K., Plaks, V., and Werb, Z. (2010). Matrix metalloproteinases: regulators of the tumor microenvi- ronment. Cell 141, 52-67.
60. Labrecque, L., Nyalendo, C., Langlois, S., Durocher, Y., Roghi, C., Murphy, G., Gingras, D., and Beliveau, R. (2004). Src-mediated tyrosine phosphoryla- tion of caveolin-1 induces its associa- tion with membrane type 1 matrix metalloproteinase. J. Biol. Chem. 279, 52132-52140.
61. Lafleur, M. A., Handsley, M. M., and Edwards, D. R. (2003). Metalloproteinases and their inhibi- tors in angiogenesis. Expert Rev. Mol. Med. 5, 1-39.
62. Langlois, S., Gingras, D., and Beliveau, R. (2004). Membrane type 1-matrix met- alloproteinase (MT1-MMP) cooper- ates with sphingosine 1-phosphate to induce endothelial cell migration and morphogenic differentiation. Blood 103, 3020-3028.
63. Lehti, K., Allen, E., Birkedal-Hansen, H., Holmbeck, K., Miyake, Y., Chun, T. H., and Weiss, S. J. (2005). An MT1-MMP- PDGF receptor-beta axis regulates mural cell investment of the micro- vasculature. Genes Dev. 19, 979-991.
64. Lehti, K., Rose, N. F., Valavaara, S., Weiss, S. J., and Keski-Oja, J. (2009). MT1- MMP promotes vascular smooth muscle dedifferentiation through LRP1 processing. J. Cell Sci. 122, 126-135.
65. Levental, K. R., Yu, H., Kass, L., Lakins, J. N., Egeblad, M., Erler, J. T., Fong, S. F., Csiszar, K., Giaccia, A., Weninger, W., Yamauchi, M., Gasser, D. L., and Weaver, V. M. (2009). Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 139, 891-906.
66. Lindahl, P., Johansson, B. R., Leveen, P., and Betsholtz, C. (1997). Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 277, 242-245.
67. Liu, X., Wu, H., Byrne, M., Jeffrey, J., Krane, S., and Jaenisch, R. (1995). A targeted mutation at the known col- lagenase cleavage site in mouse type I collagen impairs tissue remodeling. J. Cell Biol. 130, 227-237.
68. Lopez-Otin, C., and Matrisian, L. M. (2007). Emerging roles of proteases in tumour suppression. Nat. Rev. Cancer 7, 800-808.
69. Lucchesi, P. A., Sabri, A., Belmadani, S., and Matrougui, K. (2004). Involvement of metalloproteinases 2/9 in epidermal growth factor receptor transactivation in pressure-induced myogenic tone in mouse mesenteric resistance arteries. Circulation 110, 3587-3593.
70. Lyden, D., Hattori, K., Dias, S., Costa, C., Blaikie, P., Butros, L., Chadburn, A., Heissig, B., Marks, W., Witte, L., Wu, Y., Hicklin, D., Zhu, Z., Hackett, N. R., Crystal, R. G., Moore, M. A., Hajjar, K. A., Manova, K., Benezra, R., and Rafii, S. (2001). Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat. Med. 7, 1194-1201.
71. Magzoub, M., Jin, S., and Verkman, A. S. (2008). Enhanced macromolecule dif- fusion deep in tumors after enzymatic digestion of extracellular matrix col- lagen and its associated proteoglycan decorin. FASEB J. 22, 276-284.
72. Malinda, K. M., Nomizu, M., Chung, M., Delgado, M., Kuratomi, Y., Yamada, Y., Kleinman, H. K., and Ponce, M. L. (1999). Identification of laminin alpha1 and beta1 chain peptides active for endothelial cell adhesion, tube for- mation, and aortic sprouting. FASEB J. 13, 53-62.
73. Miles, A. A., and Miles, E. M. (1952). Vascular reactions to histamine, histamine-liberator and leukotaxine in the skin of guinea pigs. J. Physiol. 118, 228-257.
74. Mimura, T., Han, K. Y., Onguchi, T., Chang, J. H., Kim, T. I., Kojima, T., Zhou, Z., and Azar, D. T. (2009). MT1- MMP-mediated cleavage of decorin in corneal angiogenesis. J. Vasc. Res. 46, 541-550.
75. Montesano, R., Mouron, P., Amherdt, M., and Orci, L. (1983). Collagen matrix promotes reorganization of pancreatic endocrine cell monolayers into islet- like organoids. J. Cell Biol. 97, 935-939.
76. Netti, P. A., Berk, D. A., Swartz, M. A., Grodzinsky, A. J., and Jain, R. K. (2000). Role of extracellular matrix assembly in interstitial transport in solid tumors. Cancer Res. 60, 2497-2503.
77. Nishiuchi, R., Takagi, J., Hayashi, M., Ido, H., Yagi, Y., Sanzen, N., Tsuji, T., Yamada, M., and Sekiguchi, K. (2006). Ligand-binding specificities of laminin-binding integrins: a com- prehensive survey of laminin-integrin interactions using recombinant alpha- 3beta1, alpha6beta1, alpha7beta1 and alpha6beta4 integrins. Matrix Biol. 25, 189-197.
78. Noel, A., Jost, M., and Maquoi, E. (2008). Matrix metalloproteinases at cancer tumor-host interface. Semin. Cell Dev. Biol. 19, 52-60.
79. Ohuchi, E., Imai, K., Fujii, Y., Sato, H., Seiki, M., and Okada, Y. (1997). Membrane type 1 matrix metallo- proteinase digests interstitial colla- gens and other extracellular matrix macromolecules. J. Biol. Chem. 272, 2446-2451.
80. Onimaru, M., Yonemitsu, Y., Suzuki, H., Fujii, T., and Sueishi, K. (2010). An autocrine linkage between matrix metalloproteinase-14 and Tie-2 via ectodomain shedding modulates angiopoietin-1-dependent function in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 30, 818-826.
81. Oshitari, T., Polewski, P., Chadda, M., Li, A. F., Sato, T., and Roy, S. (2006). Effect of combined antisense oligo- nucleotides against high-glucose- and diabetes-induced overexpression of extracellular matrix components and increased vascular permeability. Diabetes 55, 86-92.
82. Ottaviano, A. J., Sun, L., Ananthanarayanan, V., and Munshi, H. G. (2006). Extracellular matrix- mediated membrane-type 1 matrix metalloproteinase expression in pancreatic ductal cells is regulated by transforming growth factor-beta1. Cancer Res. 66, 7032-7040.
83. Ouyang, M., Huang, H., Shaner, N. C., Remacle, A. G., Shiryaev, S. A., Strongin, A. Y., Tsien, R. Y., and Wang, Y. (2010). Simultaneous visualization of protumorigenic Src and MT1- MMP activities with fluorescence resonance energy transfer. Cancer Res. 70, 2204-2212.
84. Page-McCaw, A., Ewald, A. J., and Werb, Z. (2007). Matrix metalloproteinases and the regulation of tissue remodelling. Nat. Rev. Mol. Cell Biol. 8, 221-233.
85. Paku, S. (1998). Current concepts of tumor-induced angiogenesis. Pathol. Oncol. Res. 4, 62-75.
86. Park, J. S., Seo, J., Kim, Y. O., Lee, H. S., and Jo, I. (2009). Coordinated regu- lation of angiopoietin-1 and vascular endothelial growth factor by arsenite in human brain microvascular peri- cytes: implications of arsenite-induced vascular dysfunction. Toxicology 264, 26-31.
87. Ponce, M. L., and Kleinman, H. K. (2003). Identification of redundant ang- iogenic sites in laminin alpha1 and gamma1 chains. Exp. Cell Res. 285, 189-195.
88. Purhonen, S., Palm, J., Rossi, D., Kaskenpaa, N., Rajantie, I., Yla- Herttuala, S., Alitalo, K., Weissman, I. L., and Salven, P. (2008). Bone mar- row-derived circulating endothelial precursors do not contribute to vas- cular endothelium and are not needed for tumor growth. Proc. Natl. Acad. Sci. U.S.A. 105, 6620-6625.
89. Raza, A., Franklin, M. J., and Dudek, A. Z. (2010). Pericytes and vessel matu- ration during tumor angiogenesis and metastasis. Am. J. Hematol. 85, 593-598.
90. Rebustini, I. T., Myers, C., Lassiter, K. S., Surmak, A., Szabova, L., Holmbeck, K., Pedchenko, V., Hudson, B. G., and Hoffman, M. P. (2009). MT2-MMP- dependent release of collagen IV NC1 domains regulates submandibular gland branching morphogenesis. Dev. Cell 17, 482-493.
91. Rundhaug, J. E. (2005). Matrix metallo- proteinases and angiogenesis. J. Cell. Mol. Med. 9, 267-285.
92. Rutkowski, J. M., Moya, M., Johannes, J., Goldman, J., and Swartz, M. A. (2006). Secondary lymphedema in the mouse tail: lymphatic hyperplasia, VEGF-C upregulation, and the protective role of MMP-9. Microvasc. Res. 72, 161-171.
93. Sabbota, A. L., Kim, H. R., Zhe, X., Fridman, R., Bonfil, R. D., and Cher, M. L. (2010). Shedding of RANKL by tumor-associated MT1-MMP activates Src-dependent prostate cancer cell migration. Cancer Res. 70, 5558-5566.
94. Sato, Y. (1995). Activation of latent TGF-beta at the vascular wall-roles of endothelial cells and mural pericytes or smooth muscle cells. J. Atheroscler. Thromb. 2, 24-29.
95. Senger, D. R., Perruzzi, C. A., Streit, M., Koteliansky, V. E., de Fougerolles, A. R., and Detmar, M. (2002). The alpha(1)beta(1) and alpha(2)beta(1) integrins provide critical support for vascular endothelial growth factor signaling, endothelial cell migration, and tumor angiogenesis. Am. J. Pathol. 160, 195-204.
96. Shields, M. A., Dangi-Garimella, S., Krantz, S. B., Bentrem, D. J., and Munshi, H. G. (2011). Pancreatic can- cer cells respond to type i collagen by inducing snail expression to promote membrane type 1 matrix metallopro- teinase-dependent collagen invasion. J. Biol. Chem. 286, 10495-10504.
97. Shirvaikar, N., Marquez-Curtis, L. A., Ratajczak, M. Z., and Janowska- Wieczorek, A. (2011). Hyaluronic acid and thrombin upregulate MT1-MMP through PI3K and Rac-1 signaling and prime the homing-related responses of cord blood hematopoietic stem/ progenitor cells. Stem Cells Dev. 20, 19-30.
98. Shirvaikar, N., Marquez-Curtis, L. A., Shaw, A. R., Turner, A. R., and Janowska-Wieczorek, A. (2010). MT1- MMP association with membrane lipid rafts facilitates G-CSF-induced hematopoietic stem/progenitor cell mobilization. Exp. Hematol. 38, 823-835.
99. Shoulders, M. D., and Raines, R. T. (2009). Collagen structure and stability. Annu. Rev. Biochem. 78, 929-958.
100. Silvestre, J. S., Mallat, Z., Tamarat, R., Duriez, M., Tedgui, A., and Levy, B. I. (2001). Regulation of matrix metalloproteinase activity in ischemic tissue by interleukin-10: role in ischemia-induced angiogenesis. Circ. Res. 89, 259-264.
101. Smadja, D. M., d'Audigier, C., Bieche, I., Evrard, S., Mauge, L., Dias, J. V., Labreuche, J., Laurendeau, I., Marsac, B., Dizier, B., Wagner-Ballon, O., Boisson-Vidal, C., Morandi, V., Duong-Van-Huyen, J. P., Bruneval, P., Dignat-George, F., Emmerich, J., and Gaussem, P. (2011). Thrombospondin-1 is a plasmatic marker of peripheral arterial disease that modulates endothelial progenitor cell angiogenic properties. Arterioscler. Thromb. Vasc. Biol. 31, 551-559.
102. Sohail, A., Sun, Q., Zhao, H., Bernardo, M. M., Cho, J. A., and Fridman, R. (2008). MT4-(MMP17) and MT6-MMP (MMP25), a unique set of membrane- anchored matrix metalloproteinases: properties and expression in cancer. Cancer Metastasis Rev. 27, 289-302.
103. Sounni, N. E., Dehne, K., van Kempen, L., Egeblad, M., Affara, N. I., Cuevas, I., Wiesen, J., Junankar, S., Korets, L., Lee, J., Shen, J., Morrison, C. J., Overall, C. M., Krane, S. M., Werb, Z., Boudreau, N., and Coussens, L. M. (2010). Stromal regulation of vessel stability by MMP14 and TGFbeta. Dis. Model Mech. 3, 317-332.
104. Sounni, N. E., Rozanov, D. V., Remacle, A. G., Golubkov, V. S., Noel, A., and Strongin, A. Y. (2010). Timp-2 bind- ing with cellular MT1-MMP stimu- lates invasion-promoting MEK/ERK signaling in cancer cells. Int. J. Cancer 126, 1067-1078.
105. Sounni, N. E., Devy, L., Hajitou, A., Frankenne, F., Munaut, C., Gilles, C., Deroanne, C., Thompson, E. W., Foidart, J. M., and Noel, A. (2002). MT1-MMP expression promotes tumor growth and angiogenesis through an up-regulation of vascular endothelial growth factor expression. FASEB J. 16, 555-564.
106. Sounni, N. E., Janssen, M., Foidart, J. M., and Noel, A. (2003). Membrane type-1 matrix metalloproteinase and TIMP-2 in tumor angiogenesis. Matrix Biol. 22, 55-61.
107. Sounni, N. E., and Noel, A. (2005). Membrane type- matrix metalloprotei-nases and tumor progression. Biochimie 87, 329-342.
108. Sounni, N. E., Roghi, C., Chabottaux, V., Janssen, M., Munaut, C., Maquoi, E., Galvez, B. G., Gilles, C., Frankenne, F., Murphy, G., Foidart, J. M., and Noel, A. (2004). Up-regulation of vascular endothelial growth factor-A by active membrane-type 1 matrix metallo- proteinase through activation of Src- tyrosine kinases. J. Biol. Chem. 279, 13564-13574.
109. Spurbeck, W. W., Ng, C. Y., Strom, T. S., Vanin, E. F., and Davidoff, A. M. (2002). Enforced expression of tis- sue inhibitor of matrix metallopro- teinase-3 affects functional capillary morphogenesis and inhibits tumor growth in a murine tumor model. Blood 100, 3361-3368.
110. Stratman, A. N., Saunders, W. B., Sacharidou, A., Koh, W., Fisher, K. E., Zawieja, D. C., Davis, M. J., and Davis, G. E. (2009). Endothelial cell lumen and vascular guidance tunnel forma- tion requires MT1-MMP-dependent proteolysis in 3-dimensional collagen matrices. Blood 114, 237-247.
111. Suzuki, M., Raab, G., Moses, M. A., Fernandez, C. A., and Klagsbrun, M. (1997). Matrix metalloproteinase-3 releases active heparin-binding EGF- like growth factor by cleavage at a specific juxtamembrane site. J. Biol. Chem. 272, 31730-31737.
112. Takino, T., Tsuge, H., Ozawa, T., and Sato, H. (2010). MT1-MMP pro- motes cell growth and ERK activa- tion through c-Src and paxillin in three-dimensional collagen matrix. Biochem. Biophys. Res. Commun. 396, 1042-1047.
113. Tam, E. M., Moore, T. R., Butler, G. S., and Overall, C. M. (2004). Characterization of the distinct col- lagen binding, helicase and cleavage mechanisms of matrix metalloprotei- nase 2 and 14 (gelatinase A and MT1- MMP): the differential roles of the MMP hemopexin c domains and the MMP-2 fibronectin type II modules in collagen triple helicase activities. J. Biol. Chem. 279, 43336-43344.
114. Tatti, O., Vehvilainen, P., Lehti, K., and Keski-Oja, J. (2008). MT1-MMP releases latent TGF-beta1 from endothelial cell extracellular matrix via proteolytic processing of LTBP-1. Exp. Cell Res. 314, 2501-2514.
115. Vagima, Y., Avigdor, A., Goichberg, P., Shivtiel, S., Tesio, M., Kalinkovich, A., Golan, K., Dar, A., Kollet, O., Petit, I., Perl, O., Rosenthal, E., Resnick, I., Hardan, I., Gellman, Y. N., Naor, D., Nagler, A., and Lapidot, T. (2009). MT1-MMP and RECK are involved in human CD34+ progenitor cell reten- tion, egress, and mobilization. J. Clin. Invest. 119, 492-503.
116. Wiig, H., Gyenge, C., Iversen, P. O., Gullberg, D., and Tenstad, O. (2008). The role of the extracellular matrix in tissue distribution of macromolecules in normal and pathological tissues: potential therapeutic consequences. Microcirculation 15, 283-296.
117. Wiig, H., Tenstad, O., Iversen, P. O., Kalluri, R., and Bjerkvig, R. (2010). Interstitial fluid: the overlooked component of the tumor micro- environment? Fibrogenesis Tissue Repair 3, 12.
118. Xian, X., Hakansson, J., Stahlberg, A., Lindblom, P., Betsholtz, C., Gerhardt, H., and Semb, H. (2006). Pericytes limit tumor cell metastasis. J. Clin. Invest. 116, 642-651.
119. Xu, J., Rodriguez, D., Petitclerc, E., Kim, J. J., Hangai, M., Moon, Y. S., Davis, G. E., Brooks, P. C., and Yuen, S. M. (2001). Proteolytic exposure of a cryptic site within collagen type IV is required for angiogenesis and tumor growth in vivo. J. Cell Biol. 154, 1069-1079.
120. Xu, Y., Gurusiddappa, S., Rich, R. L., Owens, R. T., Keene, D. R., Mayne, R., Hook, A., and Hook, M. (2000). Multiple binding sites in collagen type I for the integrins alpha1beta1 and alpha2beta1. J. Biol. Chem. 275, 38981-38989.
121. Yana, I., Sagara, H., Takaki, S., Takatsu, K., Nakamura, K., Nakao, K., Katsuki, M., Taniguchi, S., Aoki, T., Sato, H., Weiss, S. J., and Seiki, M. (2007). Crosstalk between neovessels and mural cells directs the site-specific expression of MT1-MMP to endothelial tip cells. J. Cell. Sci. 120, 1607-1614.
122. Yoon, C. H., Hur, J., Park, K. W., Kim, J. H., Lee, C. S., Oh, I. Y., Kim, T. Y., Cho, H. J., Kang, H. J., Chae, I. H., Yang, H. K., Oh, B. H., Park, Y. B., and Kim, H. S. (2005). Synergistic neovasculariza- tion by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases. Circulation 112, 1618-1627.
123. Yu, W. H., Woessner, J. F. Jr., McNeish, J. D., and Stamenkovic, I. (2002). CD44 anchors the assembly of matrilysin/ MMP-7 with heparin-binding epi- dermal growth factor precursor and ErbB4 and regulates female reproduc- tive organ remodeling. Genes Dev. 16, 307-323.
124. Zhou, Z., Apte, S. S., Soininen, R., Cao, R., Baaklini, G. Y., Rauser, R. W., Wang, J., Cao, Y., and Tryggvason, K. (2000). Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metallopro- teinase I. Proc. Natl. Acad. Sci. U.S.A. 97, 4052-4057.
125. Zucker, S., Pei, D., Cao, J., and Lopez-Otin, C. (2003). Membrane type-matrix metalloproteinases (MT-MMP). Curr. Top. Dev. Biol. 54, 1-74.